Related Experiment Videos
Changes in antischistosomal drug usage patterns in rural Qalyubia, Egypt
D F McNeeley1, M A Habib, S H Morgan
1School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
The American Journal of Tropical Medicine and Hygiene
|February 1, 1990
Summary
Antischistosomal drug use in Egypt
Area of Science:
- Epidemiology
- Parasitology
- Public Health
Background:
- Schistosomiasis remains a significant public health concern in the Nile Delta region.
- Understanding antischistosomal drug utilization is crucial for effective disease control strategies.
Purpose of the Study:
- To investigate current patterns of antischistosomal drug usage in two villages in the Nile Delta.
- To identify changes in drug administration methods compared to previous studies.
Main Methods:
- A drug history was obtained via interviews from a sample of households in Halaba and Kharkania villages.
- Data collected included drug type, administration route, and treatment completion rates.
Main Results:
- Low reported use of antischistosomal drugs in the past four years (3% in Halaba, 0.4% in Kharkania).
- Predominance of oral praziquantel and niridazole, with 95% treatment completion.
- Shift from injectable compounds to oral formulations since an earlier study in Halaba.
Conclusions:
- Current antischistosomal drug usage in the studied Nile Delta villages is low.
- A significant transition towards oral praziquantel and niridazole has occurred.
- These findings highlight evolving treatment practices for schistosomiasis in the region.